Does extended-release somatostatin slow the growth of renal cysts in autosomal-dominant polycystic kidney disease?

被引：3

作者：

Grantham, JJ ^{[1
]}

机构：

[1] Univ Kansas, Med Ctr, Kansas City, KS 66160 USA

来源：

NATURE CLINICAL PRACTICE NEPHROLOGY | 2006年 / 2卷 / 02期

关键词：

cyst volume; polycystic kidney disease; somatostatin;

D O I：

10.1038/ncpneph0082

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：66 / 67

页数：2

共 4 条

[1] Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort [J].

Chapman, AB ;

Guay-Woodford, LM ;

Grantham, JJ ;

Torres, VE ;

Bae, KT ;

Baumgarten, DA ;

Kenney, PJ ;

King, BF ;

Glockner, JF ;

Wetzel, LH ;

Brummer, ME ;

O'Neill, WC ;

Robbin, ML ;

Bennett, WM ;

Klahr, S ;

Hirschman, GH ;

Kimmel, PL ;

Thompson, PA ;

Miller, JP .

KIDNEY INTERNATIONAL, 2003, 64 (03) :1035-1045

[2] Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist [J].

Gattone, VH ;

Wang, XF ;

Harris, PC ;

Torres, VE .

NATURE MEDICINE, 2003, 9 (10) :1323-1326

[3] Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease [J].

Torres, VE ;

Wang, XF ;

Qian, Q ;

Somlo, S ;

Harris, PC ;

Gattone, VH .

NATURE MEDICINE, 2004, 10 (04) :363-364

[4] Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK [J].

Wang, XF ;

Gattone, V ;

Harris, PC ;

Torres, VE .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (04) :846-851

← 1 →